This medication requires a valid prescription. Please refer to the ‘Prescription Guide’ for details.
Note: We can assist only if the medicine is unavailable in your country.”
Daurismo (glasdegib)
General Description:
Daurismo (glasdegib) is an oral prescription medication used in combination with low-dose cytarabine to treat adults with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive chemotherapy. It works as a Hedgehog pathway inhibitor, targeting and blocking the smoothened (SMO) receptor to help prevent the growth and spread of leukemia cells.
Daurismo is taken orally under the supervision of a qualified oncologist, with the dosage determined based on individual patient factors and treatment response.
Getting Daurismo (glasdegib) in India
Daurismo has been approved by major international regulatory authorities, including the U.S. FDA, EMA, and Health Canada, for the treatment of acute myeloid leukemia. While it may not yet be commercially available in India, eligible patients can access it legally through a Named Patient Program (NPP) under the guidance of a licensed physician.
MitoGENE assists Indian patients in obtaining Daurismo safely by coordinating regulatory documentation, import permits, and shipping logistics to ensure a compliant and secure process.
Disease Indication:
• Acute Myeloid Leukemia (AML)
Manufacturer:
Pfizer Pharma GmbH
Usage:
Oral Tablets
Medicine Approved By:
• Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• Health Canada
Available Dosage Form & Package:
• 30 tablets of 100 mg
• 60 tablets of 25 mg
Shipping:
Room Temperature Shipping
Daurismo is shipped under controlled room temperature conditions (15–25°C) to maintain stability and effectiveness. Standard shipping procedures ensure the medicine remains safe and uncompromised during transit.
How to Access Daurismo (glasdegib)in India in 4 Simple Steps with MitoGENE via the Named Patient Program (NPP)?
If Daurismo (glasdegib)is not yet approved or commercially available in India, MitoGENE can assist you in accessing it legally through the Named Patient Program (NPP). Here’s how the process works:
